中华儿科杂志
中華兒科雜誌
중화인과잡지
Chinese Journal of Pediatrics
2008年
12期
919-923
,共5页
宋昉%瞿宇晋%邹丽萍%王立文%龙美娟%王旭%杨艳玲%陈倩%王红%金煜炜
宋昉%瞿宇晉%鄒麗萍%王立文%龍美娟%王旭%楊豔玲%陳倩%王紅%金煜煒
송방%구우진%추려평%왕립문%룡미연%왕욱%양염령%진천%왕홍%금욱위
脊髓性肌萎缩,儿童%基因
脊髓性肌萎縮,兒童%基因
척수성기위축,인동%기인
Spinal muscular atrophy of childhood%Gene
目的 研究儿童脊髓性肌萎缩症(SMA)运动神经元存活基因SMN1缺失和诊断的意义.方法 根据国际诊断标准、病例随访和基因分析结果对338例疑似SMA的患儿进行诊断和分型.应用PCR-酶切方法分析患儿SMN1基因外显子7和外显子8的纯合缺失.应用等位基因特异PCR结合变性高效液相色谱分析(DHPLC)方法分析患儿的SMN1基因拷贝数,确定杂合缺失.结果 (1)确诊SMA 267例,其中Ⅰ型143例,Ⅱ型82例,Ⅲ型42例,分别占53.6%、30.7%和15.7%.(2)267例SMA患儿的SMN1基因缺失分析显示:SMN1基因外显子7和8均纯合缺失为183例,占68.5%(183/267),仅外显子7纯合缺失,外显子8不缺失为34例,占12.7%(34/267),外显子7杂合缺失为33例,占12.4%(33/267),非缺失为17例,占6.4%(17/267),未见SMN1基因外显子8的单独缺失.(3)Ⅰ型和Ⅱ型SMN1基因缺失率相近.Ⅲ型SMN1基因纯合缺失率较低于Ⅰ型和Ⅱ型,杂合缺失率较高于Ⅰ型和Ⅱ型.结论 (1)我国儿童SMA的SMN1基因纯合缺失和杂合缺失频率提示,SMN1基因突变存在种族异质性,SMN1基因内微小突变需要研究.(2)SMN1基因诊断具有特异性和无创性,80%SMA患儿通过SMN1基因纯合缺失分析得到诊断.(3)Ⅲ型SMA的临床诊断和基因分析需要进一步研究.
目的 研究兒童脊髓性肌萎縮癥(SMA)運動神經元存活基因SMN1缺失和診斷的意義.方法 根據國際診斷標準、病例隨訪和基因分析結果對338例疑似SMA的患兒進行診斷和分型.應用PCR-酶切方法分析患兒SMN1基因外顯子7和外顯子8的純閤缺失.應用等位基因特異PCR結閤變性高效液相色譜分析(DHPLC)方法分析患兒的SMN1基因拷貝數,確定雜閤缺失.結果 (1)確診SMA 267例,其中Ⅰ型143例,Ⅱ型82例,Ⅲ型42例,分彆佔53.6%、30.7%和15.7%.(2)267例SMA患兒的SMN1基因缺失分析顯示:SMN1基因外顯子7和8均純閤缺失為183例,佔68.5%(183/267),僅外顯子7純閤缺失,外顯子8不缺失為34例,佔12.7%(34/267),外顯子7雜閤缺失為33例,佔12.4%(33/267),非缺失為17例,佔6.4%(17/267),未見SMN1基因外顯子8的單獨缺失.(3)Ⅰ型和Ⅱ型SMN1基因缺失率相近.Ⅲ型SMN1基因純閤缺失率較低于Ⅰ型和Ⅱ型,雜閤缺失率較高于Ⅰ型和Ⅱ型.結論 (1)我國兒童SMA的SMN1基因純閤缺失和雜閤缺失頻率提示,SMN1基因突變存在種族異質性,SMN1基因內微小突變需要研究.(2)SMN1基因診斷具有特異性和無創性,80%SMA患兒通過SMN1基因純閤缺失分析得到診斷.(3)Ⅲ型SMA的臨床診斷和基因分析需要進一步研究.
목적 연구인동척수성기위축증(SMA)운동신경원존활기인SMN1결실화진단적의의.방법 근거국제진단표준、병례수방화기인분석결과대338례의사SMA적환인진행진단화분형.응용PCR-매절방법분석환인SMN1기인외현자7화외현자8적순합결실.응용등위기인특이PCR결합변성고효액상색보분석(DHPLC)방법분석환인적SMN1기인고패수,학정잡합결실.결과 (1)학진SMA 267례,기중Ⅰ형143례,Ⅱ형82례,Ⅲ형42례,분별점53.6%、30.7%화15.7%.(2)267례SMA환인적SMN1기인결실분석현시:SMN1기인외현자7화8균순합결실위183례,점68.5%(183/267),부외현자7순합결실,외현자8불결실위34례,점12.7%(34/267),외현자7잡합결실위33례,점12.4%(33/267),비결실위17례,점6.4%(17/267),미견SMN1기인외현자8적단독결실.(3)Ⅰ형화Ⅱ형SMN1기인결실솔상근.Ⅲ형SMN1기인순합결실솔교저우Ⅰ형화Ⅱ형,잡합결실솔교고우Ⅰ형화Ⅱ형.결론 (1)아국인동SMA적SMN1기인순합결실화잡합결실빈솔제시,SMN1기인돌변존재충족이질성,SMN1기인내미소돌변수요연구.(2)SMN1기인진단구유특이성화무창성,80%SMA환인통과SMN1기인순합결실분석득도진단.(3)Ⅲ형SMA적림상진단화기인분석수요진일보연구.
Objective Spinal muscular atrophy (SMA) is an autesomal recessive disorder that results in symmetrical muscle weakness and wasting due to degeneration of the anterior horns of the spinal cord.The clinical picture of SMA is variable and childhood SMA has been classified into 3 types on the basis of the age of onset and clinical course.The survival motor neuron (SMN) gene was mapped to chromosome 5q13.The SMN1 gene has been recognized to be responsible for SMA because of homozygouse deletions or intragenic mutations in SMN1 results in childhood onset of SMA.The main objective of this study was to determine the deletion frequency of SMN1 gene and to apply gene analysis in children patients with SMA.Methods The SMA patients were diagnosed and clinically typed according to the international diagnostic criteria,following up cases,and gene analysis.The PCR enzyme assay was used to detect the homozygons deletion of SMN1 gene in SMA patients.A dosage assay that combined multiplexed allele-specific PCR and DHPLC was used to determine the copy numbers of the SMN1 and SMN2 and detect SMN1 heterozygous deletion.Results (1) A total of 267 patients with SMA were diagnosed from 338 suspicious cases and 143,82,and 42 eases were typed as types Ⅰ,Ⅱ,and Ⅲ,with the percentages of 53.6% (143/267),30.7% (82/267) and 15.7% (42/267),respectively.(2) Results of the present study showed that 68.5% (183/267)of SMA patients had homozygous deletions of exons 7 and 8 of SMN1 gene and 12.7% (34/267) had homozygons deletions of only exon 7 of SMN1 gene.The SMN1 heterozygous deletion was confirmed in 12.4% (33/267)of SMA patients.Non-deletian SMA patients accounted for 6.4% (17/267).The homozygons deletions of only exon 8 of SMNI gene could not be detected.(3) The rates of homozygous or heterozygous deletion in types Ⅰ and Ⅱ were very similar.The rate of homozygons deletion was lower in type Ⅲ than that in type Ⅰ or Ⅱ and rate of heterozygous deletion of type Ⅲ was higher than that in types Ⅰ or Ⅱ.Conclusion (1) The frequency and pattern of deletions in the Chinese children patients with SMA are significantly different from that observed in Caucasians populations.Further gene characterization and subtle mutations within the SMN1 gene need to be studied in order to define the molecular basis of SMA in the Chinese population.(2) The gene diagnosis is a special and non invasive method as compared with other methods.A total of 80% patients can be diagnosed through the analysis of the homozygous deletion of SMN1 gene.(3) The clinical diagnosis and gene detection need to be studied in future for the SMA patients with type Ⅲ.